InvestorsHub Logo
Followers 25
Posts 158
Boards Moderated 1
Alias Born 04/30/2010

Re: kklar1 post# 93836

Monday, 05/02/2016 6:34:07 PM

Monday, May 02, 2016 6:34:07 PM

Post# of 97239
$TRVN

Trevena Announces Successful End-of-Phase 2 Meeting with FDA and Outlines Phase 3 Program for Oliceridine

- Pivotal efficacy studies to start in 2Q 2016, with topline data expected in 1Q 2017, and NDA filing expected in 2H 2017 -

- Phase 3 program includes comparisons to both placebo and morphine -

- Webcast and call scheduled for today at 5:30 pm EDT -


$HEFF STATION... ALL ABOARD.... LET'S MAKE SOME MONEY

2014 Performance Dec 2013 - Feb 2014

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.